Richard Herbert Selected Research

mRNA Vaccines

12/2021

A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Herbert Research Topics

Disease

4	Paramyxoviridae Infections (Parainfluenza) 12/2022 - 11/2016
3	Infections 12/2021 - 01/2017
2	Pneumonia (Pneumonitis) 01/2024 - 11/2016
2	Bronchiolitis 01/2024 - 11/2016
1	Shock 11/2023
1	Ebola Hemorrhagic Fever 11/2023
1	Tuberculosis (Tuberculoses) 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2021
1	Wounds and Injuries (Trauma) 10/2017
1	Fever (Fevers) 01/2017
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2017
1	Virus Diseases (Viral Diseases) 01/2017

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 01/2024 - 11/2016
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 11/2016
2	COVID-19 VaccinesIBA 12/2022 - 05/2022
2	AntibodiesIBA 12/2021 - 12/2020
2	Neutralizing AntibodiesIBA 12/2020 - 11/2016
1	IgA receptor (protein B)IBA 05/2022
1	mRNA VaccinesIBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	Antiviral Agents (Antivirals)IBA 01/2017
1	InterferonsIBA 01/2017

Therapy/Procedure

1	Critical Care (Surgical Intensive Care) 11/2023
1	Therapeutics 11/2023
1	Euthanasia (Mercy Killing) 10/2017